Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
about
Pharmacological treatments for primary sclerosing cholangitis: a network meta-analysisA review of the medical treatment of primary sclerosing cholangitis in the 21st centuryDiagnosis and management of the overlap syndromes of autoimmune hepatitisDifficult treatment decisions in autoimmune hepatitis.Management of primary sclerosing cholangitis: conventions and controversiesClinical features and management of primary sclerosing cholangitis.Treatment options for primary sclerosing cholangitis.Current management of primary sclerosing cholangitis in pediatric patients.Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.New treatment strategies for primary sclerosing cholangitis.The overlap syndromes of autoimmune hepatitis.Primary sclerosing cholangitis: a review and update on therapeutic developments.A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis.Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.Management Of Primary Sclerosing Cholangitis.Update on pharmacotherapies for cholestatic liver disease.Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.Cholestatic liver diseases: new targets, new therapies
P2860
Q24193305-0AD89F43-F1F1-4C96-BF51-8492BFD6F56FQ26771816-67637D69-FE4B-4F0D-B0F7-F6589B37996BQ27003179-CA99CD4D-48B3-4E25-B644-AED0B625207EQ33688293-05D69CA0-1831-4587-A6BA-B3F49D082A98Q35962107-2AFD4D7B-D7DB-4129-8384-33A66A9DAB5DQ37182946-FDACC7EF-0F2C-4829-B4D5-45693FF57F4EQ37777156-B1CC4BCC-CFA1-4937-B796-3C675DAFE4A0Q37847138-D286352C-D028-4D02-8BDC-406C989137BDQ37866339-B66970C1-CA3F-4E1E-9E42-EEB682BBE862Q37892297-8BEAE524-326F-4B98-A4FD-682DEDD18A22Q38037392-D8ECC1A8-C16B-4452-9C79-7D7B29BA191BQ38077820-8DCDB1F7-1339-4D37-B1BB-C6384974E32AQ38584285-8EA4B22C-0DAF-4D4C-BDA7-39F7BE9DE59FQ38595151-8ADAD269-9FD7-4793-B0E6-51B939AA69E8Q38833243-8E1EA0C7-CAC1-4E82-BF29-B2BCA999E8F8Q46480411-FD226923-F1A6-479B-9284-8E6E3C9F3D85Q55111560-AE5A94C5-E819-417D-9B3B-9B5E2ADD6FE0Q55333522-3E836E1B-BE26-4EED-9EE2-4710A64A9B10Q55497458-250A7278-9350-41FF-853C-3163618A641CQ57111104-C36DC49A-BCD1-4B56-A051-80E6EE6E88C9
P2860
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
@en
type
label
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
@en
prefLabel
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
@en
P2093
P2860
P1476
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
@en
P2093
Janice L Petz
Jayant A Talwalkar
Jill C Keach
Keith D Lindor
Paul Angulo
Roberta A Jorgensen
P2860
P304
P356
10.1111/J.1572-0241.2005.40484.X
P407
P577
2005-02-01T00:00:00Z